Last reviewed · How we verify
NCT04596501: TIME
Exercise Training and Thrombotic Risk in Post-menopausal Women
NA trial testing Early and late postmenopausal women in Thrombosis in 30 participants. Status unknown.
1 December 2022
Quick facts
| Lead sponsor | University of Copenhagen |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 30 |
| Start date | 1 March 2021 |
| Primary completion | 1 December 2022 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Early and late postmenopausal women
Conditions studied
- Thrombosis — all drugs for Thrombosis →
- Menopause — all drugs for Menopause →
- Exercise Training — all drugs for Exercise Training →
- Vascular Dilation — all drugs for Vascular Dilation →
Sponsor
University of Copenhagen
Who can join
Adults 50 to 70, female only, with Thrombosis or Menopause. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
At menopausal transition, the risk of cardiovascular diseases increases. This is partly due to aging, but largely also the loss of estrogen, which has many positive effects on the circulation and protects against cardiovascular diseases. It has been suggested that the loss of estrogen may have a negative impact on the otherwise well-documented health promoting effects of exercise training, and that the time after menopause may be crucial for the effect of exercise training on the vascular function, and therefore also for the risk of thrombosis. Literature regarding the effect of exercise training on the risk of thrombosis is limited, and especially in women. The purpose of the present study is to investigate whether the same effects of exercise training in relation to thrombosis is achieved if the exercise is initiated early compared to late after menopause. The aim is to provide knowledge-based recommendations regarding exercise. Teams sports will be used as the training intervention, because team sports benefits physical health and also includes a social element.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04596501
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thrombosis
Currently open trials in the same condition.
- NCT07137429 — Platelet Volunteers, Longitudinal and Multi-omic Study · recruiting
- NCT06676904 — Neonatal Platelet Transfusion Threshold Trial · NA · recruiting
- NCT06993740 — Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient · NA · recruiting
- NCT07358416 — Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. · active not recruiting
- NCT06370273 — Thromboprophylaxis in Lower Limb Immobilisation · Phase 3 · recruiting
Other University of Copenhagen trials
Trials by the same sponsor.
- NCT07461324 — Surgeons' Prediction of Dental Surgery Complications and the Influence of Patient Characteristics: Development of an AI · not yet recruiting
- NCT07389421 — School Meals in Denmark · NA · not yet recruiting
- NCT07450690 — Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy · NA · recruiting
- NCT07302880 — The Acute Interference of Biotin in Blood Analysis · NA · not yet recruiting
- NCT07312981 — The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04596501 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Copenhagen
- Last refreshed: 10 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04596501.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing